Wolverine peptide stack (BPC-157 and TB-500): what is in it and does it work?

What is in the Wolverine stack?

Wolverine stack contains BPC-157 and TB-500 (thymosin beta-4). The name refers to the pair, not a fixed product. It is sold as a premixed vial, as two separate vials, and as oral capsules, with amounts and ratios that vary by seller. Products sold as TB-500 may contain full-length thymosin beta-4 or a short fragment, and labels rarely say which. PeptideAgent does not name or link sellers.

Also searched as: Wolverine peptide; Wolverine peptide stack; BPC-157 and TB-500; BPC-157 TB-500 blend; BPC 157 and TB 500.

Grades and statuses come from each peptide's own record and update with it. Grades follow the methodology.

Why are these peptides combined in the Wolverine stack?

The name borrows a comic-book character who heals fast. The logic offered is that the two peptides work on repair by different routes: BPC-157 is said to promote blood vessel growth and tendon cell outgrowth, and thymosin beta-4 binds actin and drives cell migration into wounds.

Both mechanisms come from animal and cell studies. In rats, BPC-157 improved tendon healing, cell survival, and cell migration, and thymosin beta-4 sped full thickness wound closure. Whether the two effects add up, overlap, or interfere has never been measured. [1] [2] [3]

Has the Wolverine stack been studied?

No published study has tested BPC-157 and TB-500 together in humans or animals, and PubMed indexes no trial of the combination.

Alone, each has thin human data. A 2025 systematic review of BPC-157 in orthopaedic sports medicine included 36 studies, 35 of them preclinical; the one clinical report was a retrospective series in which 7 of 12 people with knee pain reported relief after an injection into the joint. It found no clinical safety data. Across the wider literature, BPC-157 has three small uncontrolled pilot reports (knee pain, interstitial cystitis, IV safety), with no control group. Full-length thymosin beta-4 has small phase 1 and phase 2 human trials (IV safety, eye drops for dry eye, topical gel for skin ulcers). None tested injected TB-500 for injury healing.

The evidence grade of the stack therefore cannot be higher than that of its ingredients, and both are graded on animal data. [4] [5] [11] [12] [13]

What each ingredient has shown alone

• BPC-157 (animal-only evidence). A 15 amino acid peptide with strong animal healing data, no randomized human trial in PubMed, and a shifting FDA compounding status.
• TB-500 (thymosin beta-4) (animal-only evidence). Copy or fragment of the repair protein thymosin beta-4: strong animal data, small human trials of the full protein, no trial of injected TB-500; WADA banned.

Wolverine stack results and before and after claims

Before and after stories for the Wolverine stack usually describe a faster return from a tendon, joint, or muscle injury. Injuries often improve with time, rest, and rehabilitation, so recovery after starting a product does not show the product caused it.

The only human data for either peptide are BPC-157's three small uncontrolled pilot reports (knee pain, interstitial cystitis, IV safety) and small phase 1 and phase 2 trials of full-length thymosin beta-4 (IV safety, eye drops for dry eye, topical gel for skin ulcers). No study has measured healing time, strength, or pain after injected BPC-157 and TB-500 together.

A 2026 review of peptide use in sports medicine highlights the placebo effect, and its amplification on social media, as an explanation for many reported results. [4] [5] [6] [11] [12] [13]

What are the side effects of the Wolverine stack?

There is no safety study of the combination. A systematic review found no clinical safety data for BPC-157, and there are no systematic human safety data for injected TB-500.

Reported problems are injection site reactions, headache, lethargy, nausea, and dizziness, mostly anecdotal. Both peptides promote blood vessel growth or cell migration in animals, which raises a theoretical concern about existing tumors that has not been tested in people.

Unregulated products add contamination and content uncertainty, a risk the BPC-157 systematic review names directly. Both peptides are prohibited for athletes subject to anti-doping testing. [3] [5] [6] [10]

Reported for each ingredient

From each peptide's record. These were reported for the peptide alone, not for the blend. Absence of data is not evidence of safety.

Is the Wolverine stack legal?

A blend inherits the strictest status among its ingredients, because a mixed product is only as lawful as its least lawful component. For the Wolverine stack that is BPC-157 and TB-500 (thymosin beta-4): awaiting FDA final rule. The limiting ingredients were recommended for the 503A bulks list, but they cannot be lawfully compounded until FDA publishes a final rule.

• BPC-157 regulatory timeline (Under FDA review)
• TB-500 (thymosin beta-4) regulatory timeline (Under FDA review)

Why blends like this are sold as research chemicals

A drug for human use in the United States has to be FDA approved or lawfully compounded by a licensed pharmacy for a named patient under a prescription. This blend can be neither, so vials sold under its name carry labels such as “for research use only” or “not for human consumption”. That label does not make a product lawful to inject, and it means no one has checked the vial for identity, purity, sterility, or amount. [7]

WADA status

BPC-157 and TB-500 (thymosin beta-4) are prohibited at all times on the WADA list, so any product containing them is prohibited for athletes subject to anti-doping testing.

State rules: peptide laws by state. All FDA actions: regulatory tracker.

What does the Wolverine stack cost, and what can a provider lawfully offer?

Today there is no lawful compounded Wolverine stack. FDA removed BPC-157 and TB-500 from the 503A Category 2 list in April 2026, and the Pharmacy Compounding Advisory Committee recommended adding both to the 503A bulks list in July 2026. The recommendation is advisory: until FDA publishes a final rule, neither is on the bulks list, and a 503A pharmacy has no federal basis to compound them from bulk.

If FDA lists both, a licensed pharmacy could compound each under a prescription, subject to state rules. Whether a premixed two-peptide vial would be compounded is a separate question for the prescriber, the pharmacy, and the state board.

Clinic and research-chemical prices are not a lawful price. Research-chemical products are labeled not for human use and are not verified for identity or purity. [7] [8] [9]

• BPC-157 cost by channel
• TB-500 (thymosin beta-4) cost by channel
• Rules by state
• Verified provider directory

What's actually offered, and what that means for you

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. That does not make the Wolverine stack lawful. FDA's advisory committee recommended BPC-157 and TB-500 (thymosin beta-4) for the 503A bulks list in July 2026, but FDA has not published a final rule, so a pharmacy has no federal basis to compound the mix yet. [7] [8]

Enforcement is uneven. FDA mostly acts through warning letters to compounders and online sellers, Category 2 safety listings, and import alerts that let it detain shipments, rather than stopping every pharmacy. State pharmacy boards oversee pharmacies day to day, and their rules differ. [9] [14] [15] [16] [17]

What changes for you

• No FDA review of the product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [9]
• Identity, purity, sterility, and dose accuracy can vary from batch to batch. [16]
• Insurance rarely covers it, so you usually pay cash.
• For tested athletes, the Wolverine stack contains at least one ingredient that is prohibited at all times on the WADA list. [10]

What to check

These checks lower some risks, but they do not make an unlawfully compounded product lawful or safe. Check for:

• A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [9]
• A real evaluation by a licensed prescriber, not just an online form.
• A certificate of analysis for the specific batch.

Compare the ingredients

• BPC-157 vs TB-500
• BPC-157 vs ARA-290 (cibinetide)
• BPC-157 vs GHK-Cu
• BPC-157 vs KPV
• TB-500 vs GHK-Cu

Blends that share an ingredient

• GLOW: GLOW is a gray-market mix of GHK-Cu, BPC-157, and TB-500 sold for skin and healing. No study has tested it, and injectable GHK-Cu has no lawful path.
• KLOW: KLOW is GLOW plus KPV: GHK-Cu, BPC-157, TB-500, and KPV in one vial. No study has tested it, and injectable GHK-Cu has no lawful path.

Frequently asked questions

From the blog

• Klow vs Glow peptide: what KPV adds and what is known

  Klow is the Glow blend (GHK-Cu, BPC-157, TB-500) plus KPV. Each ingredient compared, what KPV is claimed to add, how both relate to the Wolverine stack, and why no study tests either blend.

• Peptide before and after: trial results vs marketing photos

  Measured peptide before and after results: GLP-1 weight change, tesamorelin visceral fat, and regain after stopping, compared with Glow, GHK-Cu, BPC-157, and Wolverine claims.

• Peptide stacks: what each common component has shown alone

  No trial has tested a multi-peptide stack for muscle growth or fat loss. Nine common stack components ranked by their own human evidence, legal status, and WADA status. No protocols.

• TB-500 vs thymosin beta-4: is it the same peptide?

  TB-500 is not the same molecule as thymosin beta-4. What each one is, which has human data, what is known about capsules and sprays, and what the evidence says about cancer.

• BPC-157 before and after: reviews, results, and what controlled studies show

  BPC-157 reviews and before and after stories are everywhere. Controlled results exist only in rats. What the animal healing timelines show, what the human pilots found, and why anecdotes mislead.

• Peptides for muscle growth, ranked by human evidence

  MK-677, sermorelin, tesamorelin, CJC-1295, IGF-1 LR3, and more ranked by human evidence. None is approved for muscle growth, and all ten are banned in tested sport.

Sources

Numbered citations above point to these primary sources. PubMed entries link to the indexed abstract.